NCT00492414

Brief Summary

Panic disorder(PD)is a disabling psychiatric condition associated with significant impairment in psychosocial, occupational functioning and quality of life, as mentioned by mogotsi et al. So, most patients with panic disorder suffers from the consequences of the impairment in occupational function. This impairment is not only individual problem, but also social one. Since productivity is very important item required to employees, lost productive time among workers with psychiatric illness should be reduced by the proper management. But few data were reported in this field by now.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 27, 2007

Completed
Last Updated

August 8, 2007

Status Verified

March 1, 2007

First QC Date

June 26, 2007

Last Update Submit

August 7, 2007

Conditions

Panic Disorder

Keywords

Panic disorder (PD)

Interventions

Paroxetine CRDRUG

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female outpatients aged 20-50 years
  • In female, is eligible to enter this study if she is if
  • Non-childbearing potential(note:women who are 6 months post-menopausal are not considered women of child-bearing potential)
  • child-bearing potential, has a negative urine dipstick pregnancy test, and is practicing a clinically acceptable method of contraception such as oral contraception, surgical sterilization, I.U.D.,systemic contraception, or double barrier contraception(any two of diaphragm/spermicidal foar/condom)
  • Subject currently meets the diagnosis for PD according to korean version of Anxiety Disorder Interview Schedule for DSM-IV(ADIS-IV) through a comprehensive psychiatric evaluation and not being treated currently.
  • Subject must have the ability to comprehend the key components of the consent form and provide informed consent.

You may not qualify if:

  • Subject who has a history of any other major medical or psychiatric illnesses except PD or PD with major depressive disorder.
  • Subject who retired or left his job or who plan to retire within two years.
  • is a current homicidal or suicidal risk in the investigator's judgement.
  • is currently pregnant, lactating or planning to become pregnant within the next 3 months
  • is currently participating in any other clinical trial or taking any non-approved or experimental medication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul Paik Hospital, Inje University

Seoul, Seoul, South Korea

RECRUITING

MeSH Terms

Conditions

Panic Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • Jong-Min Woo, Master

    Seoul Paik Hospital, Inje University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Eun-Joo Jung

CONTACT

+82-2-2270-0940menfipro@naver.com

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 26, 2007

First Posted

June 27, 2007

Last Updated

August 8, 2007

Record last verified: 2007-03

Locations

KR(1)